Nisa Investment Advisors LLC decreased its stake in Cardinal Health, Inc. (NYSE:CAH) by 0.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 113,241 shares of the company’s stock after selling 225 shares during the period. Nisa Investment Advisors LLC’s holdings in Cardinal Health were worth $8,779,000 at the end of the most recent quarter.
A number of other hedge funds also recently added to or reduced their stakes in the company. HL Financial Services LLC boosted its stake in shares of Cardinal Health by 0.3% in the first quarter. HL Financial Services LLC now owns 11,887 shares of the company’s stock valued at $969,000 after buying an additional 38 shares during the last quarter. Edmond DE Rothschild Holding S.A. boosted its stake in shares of Cardinal Health by 0.9% in the first quarter. Edmond DE Rothschild Holding S.A. now owns 4,321 shares of the company’s stock valued at $353,000 after buying an additional 39 shares during the last quarter. Private Trust Co. NA boosted its stake in shares of Cardinal Health by 0.3% in the first quarter. Private Trust Co. NA now owns 13,731 shares of the company’s stock valued at $1,119,000 after buying an additional 41 shares during the last quarter. Alpha Windward LLC boosted its stake in shares of Cardinal Health by 1.8% in the first quarter. Alpha Windward LLC now owns 2,282 shares of the company’s stock valued at $186,000 after buying an additional 41 shares during the last quarter. Finally, Honkamp Krueger Financial Services Inc. boosted its stake in shares of Cardinal Health by 1.3% in the first quarter. Honkamp Krueger Financial Services Inc. now owns 4,575 shares of the company’s stock valued at $373,000 after buying an additional 60 shares during the last quarter. 87.09% of the stock is currently owned by institutional investors.
Shares of Cardinal Health, Inc. (CAH) traded down 0.49% during trading on Friday, reaching $66.98. 1,750,306 shares of the company’s stock traded hands. Cardinal Health, Inc. has a 1-year low of $62.70 and a 1-year high of $84.88. The company has a 50 day moving average price of $75.67 and a 200 day moving average price of $76.86. The stock has a market capitalization of $21.17 billion, a PE ratio of 16.62 and a beta of 0.80.
Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.07. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The business had revenue of $32.97 billion during the quarter, compared to analysts’ expectations of $32.73 billion. During the same period in the previous year, the firm earned $1.14 earnings per share. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. On average, equities analysts forecast that Cardinal Health, Inc. will post $4.97 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be issued a $0.4624 dividend. The ex-dividend date is Friday, September 29th. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.76%. Cardinal Health’s dividend payout ratio (DPR) is 45.79%.
COPYRIGHT VIOLATION WARNING: This news story was originally posted by BNB Daily and is the sole property of of BNB Daily. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.baseball-news-blog.com/2017/08/13/nisa-investment-advisors-llc-sells-225-shares-of-cardinal-health-inc-cah-updated-updated-updated.html.
Several equities analysts recently issued reports on CAH shares. Tigress Financial started coverage on shares of Cardinal Health in a report on Friday, April 28th. They set a “neutral” rating for the company. Zacks Investment Research lowered shares of Cardinal Health from a “hold” rating to a “sell” rating in a report on Friday, April 28th. Vetr lowered shares of Cardinal Health from a “buy” rating to a “hold” rating and set a $77.92 target price for the company. in a report on Thursday, June 1st. Credit Suisse Group reaffirmed a “buy” rating and set a $81.00 target price on shares of Cardinal Health in a report on Tuesday, May 2nd. Finally, BidaskClub lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 11th. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $80.46.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.